Novacyt S.A. (NVYTF)
USD 0.64
(0.0%)
USD 0.64
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -30.36 Million GBP | 64.73% |
| 2022 | -86.1 Million GBP | 13.79% |
| 2021 | -99.87 Million GBP | -11.73% |
| 2020 | -89.38 Million GBP | -1244.1% |
| 2019 | 7.81 Million EUR | 104.31% |
| 2018 | 3.82 Million EUR | 1053.02% |
| 2017 | -401.26 Thousand EUR | -113.85% |
| 2016 | 2.89 Million EUR | 37.95% |
| 2015 | 2.1 Million EUR | 329.77% |
| 2014 | -914.07 Thousand EUR | -867.76% |
| 2013 | -94.45 Thousand EUR | -175.12% |
| 2012 | 125.73 Thousand EUR | -84.84% |
| 2011 | 829.51 Thousand EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | -81.34 Million GBP | 12.26% |
| 2023 Q1 | -92.7 Million GBP | -7.67% |
| 2023 Q4 | -30.36 Million GBP | 0.0% |
| 2023 FY | -30.36 Million GBP | 64.73% |
| 2022 Q2 | -97.97 Million GBP | 0.0% |
| 2022 FY | -86.1 Million GBP | 13.79% |
| 2022 Q4 | -86.1 Million GBP | 12.87% |
| 2022 Q3 | -98.81 Million GBP | -0.86% |
| 2021 FY | -99.87 Million GBP | -11.73% |
| 2021 Q4 | -99.87 Million GBP | 0.0% |
| 2021 Q2 | -75.13 Million GBP | 0.0% |
| 2020 Q2 | -15.94 Million EUR | 0.0% |
| 2020 Q4 | -89.38 Million GBP | 0.0% |
| 2020 FY | -89.38 Million GBP | -1244.1% |
| 2019 FY | 7.81 Million EUR | 104.31% |
| 2019 Q4 | 9.14 Million EUR | 0.0% |
| 2019 Q2 | 7.26 Million EUR | 0.0% |
| 2018 Q4 | 3.82 Million EUR | 0.0% |
| 2018 FY | 3.82 Million EUR | 1053.02% |
| 2018 Q2 | 3.68 Million EUR | 0.0% |
| 2017 Q4 | -400.37 Thousand EUR | 0.0% |
| 2017 FY | -401.26 Thousand EUR | -113.85% |
| 2017 Q2 | 2.46 Million EUR | 0.0% |
| 2016 Q4 | 2.89 Million EUR | 0.0% |
| 2016 FY | 2.89 Million EUR | 37.95% |
| 2016 Q2 | 3.34 Million EUR | 0.0% |
| 2015 Q2 | 43.5 Thousand EUR | 0.0% |
| 2015 FY | 2.1 Million EUR | 329.77% |
| 2015 Q4 | 2.1 Million EUR | 0.0% |
| 2014 Q4 | -914.07 Thousand EUR | 0.0% |
| 2014 Q2 | -209.87 Thousand EUR | 0.0% |
| 2014 FY | -914.07 Thousand EUR | -867.76% |
| 2013 FY | -94.45 Thousand EUR | -175.12% |
| 2012 FY | 125.73 Thousand EUR | -84.84% |
| 2011 FY | 829.51 Thousand EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | -26.23 Million USD | -15.768% |
| Manhattan Scientifics, Inc. | -7000.00 USD | -433726.814% |
| Össur hf. | 395.08 Million USD | 107.687% |
| QHSLab, Inc. | 1.72 Million USD | 1855.399% |
| Wellstar International, Inc. | 51.36 Million USD | 159.12% |
| Össur hf. | 395.08 Million USD | 107.687% |
| CVR Medical Corp. | - USD | Infinity% |
| Bionovate Technologies Corp | - USD | Infinity% |
| Escalon Medical Corp. | 315.68 Thousand USD | 9719.646% |
| Aurora Spine Corporation | 1.9 Million USD | 1691.896% |
| BrainsWay Ltd. | -10.32 Million USD | -194.262% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| BioElectronics Corporation | 14.82 Million USD | 304.821% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 267.537% |
| Vivos Inc. | -1.59 Million USD | -1807.186% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | 6331.443% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | -5513.431% |
| Zecotek Photonics Inc. | 2.76 Million USD | 1199.31% |
| Avitar, Inc. | 5.17 Million USD | 687.255% |
| Nanomix Corporation | 11.38 Million USD | 366.638% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | -557.716% |
| Theraclion SA | -5.86 Million EUR | -417.822% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Positron Corporation | 1.68 Million USD | 1900.239% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 1985.218% |
| Lombard Medical, Inc. | 11.49 Million USD | 364.183% |
| ALR Technologies Inc. | 19.14 Million USD | 258.594% |
| Stratec SE | 119.12 Million USD | 125.493% |
| Vycor Medical, Inc. | 1.05 Million USD | 2984.057% |
| Heart Tronics, Inc. | 54.99 Thousand USD | 55319.342% |
| MicroPort Scientific Corporation | 673.58 Million USD | 104.508% |
| VMS Rehab Systems, Inc. | 133.52 USD | 22744166.058% |
| NewCardio, Inc. | 2.41 Million USD | 1357.455% |
| Guided Therapeutics, Inc. | 1.46 Million USD | 2170.068% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | 4913.277% |
| Odyssey Group International, Inc. | 2.1 Million USD | 1540.741% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | 4843.521% |
| Wellness Center USA, Inc. | 3.98 Million USD | 861.962% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 200.733% |
| IR-Med Inc. | -606 Thousand USD | -4911.201% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | -120.26% |
| Polarean Imaging plc | -5.94 Million USD | -410.682% |
| United American Healthcare Corporation | -9.32 Million USD | -225.591% |
| ECGI Holdings, Inc. | 3.17 Million USD | 1057.602% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | 32685.657% |
| Capital Group Holdings, Inc. | -3508.00 USD | -865574.943% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | 11663.517% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | 14119.739% |
| Urologix, Inc. | 4.61 Million USD | 758.026% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 821.426% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 1011.607% |
| SS Innovations International, Inc. | 1.18 Million USD | 2661.944% |
| Qualis Innovations, Inc. | 6671.00 USD | 455322.261% |
| Smith & Nephew plc | 2.77 Billion USD | 101.093% |
| NIOX Group Plc | -23.93 Million USD | -26.89% |
| Fuse Medical, Inc. | 1.75 Million USD | 1829.875% |
| Broncus Holding Corporation | -81.42 Million USD | 62.704% |
| Brain Scientific Inc. | 2.11 Million USD | 1535.31% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 233.914% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | 76869.919% |